Cannabidiol as a novel therapeutic agent in breast cancer: evidence from literature
Abstract Background Breast cancer is one of the most prevalent cancers worldwide, posing significant challenges due to its heterogeneity and the emergence of drug resistance. Cannabidiol (CBD), a non-psychoactive compound derived from Cannabis sativa, has recently gained attention for its potential...
Saved in:
| Main Authors: | Mojtaba Esmaeli, Maryam Dehghanpour Dehabadi, Ali Asghar Khaleghi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-04-01
|
| Series: | BMC Cancer |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12885-025-14175-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cannabidiol (CBD) as a potential therapeutic agent for liver cancer: a comprehensive review of current evidence
by: Mojtaba Esmaeli, et al.
Published: (2025-06-01) -
Metastatic Triple Negative Breast Cancer: The New Era of Thinking
by: Mohammed Amrallah A., et al.
Published: (2021-05-01) -
Improved Therapeutic Efficacy of Doxorubicin Chemotherapy With Cannabidiol in 4T1 Mice Breast Cancer Model
by: Koorosh Tabatabaei, et al.
Published: (2024-11-01) -
Knowledge mapping of ultrasound technology and triple-negative breast cancer: a visual and bibliometric analysis
by: Yonglin Wan, et al.
Published: (2025-07-01) -
Cytokeratin expression in breast cancer: from mechanisms, progression, diagnosis, and prognosis to therapeutic implications
by: Ensiyeh Bahadoran, et al.
Published: (2025-12-01)